Bayer sues Johnson & Johnson over marketing of prostate cancer drug
Bayer has filed a lawsuit against Johnson & Johnson, alleging misleading marketing practices related to a prostate cancer drug. The German pharmaceutical company claims that its rival overstated clinical benefits and downplayed potential risks in promotional materials aimed at physicians and patients. According to court documents, Bayer argues the campaign unfairly harmed competition and influenced prescribing decisions. Johnson & Johnson denies the allegations and says it will vigorously defend its advertising practices in court filings.
Bayer sues Johnson & Johnson over marketing of prostate cancer drug
Bayer has filed a lawsuit against Johnson & Johnson, alleging misleading marketing practices related to a prostate cancer drug. The German pharmaceutical company claims that its rival overstated clinical benefits and downplayed potential risks in promotional materials aimed at physicians and patients. According to court documents, Bayer argues the campaign unfairly harmed competition and influenced prescribing decisions. Johnson & Johnson denies the allegations and says it will vigorously defend its advertising practices in court filings.
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!